| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.099 | 0.04 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.092 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.081 | 0.08 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.055 | 0.2 |